Puteri Thailand Kena Serangan Jantung Ketika Melatih Anjing

CARI-MAL

Puteri Thailand, Puteri Bajrakitiyabha Narendira Debyavati yang dimasukkan ke hospital pada bulan lalu masih dalam keadaan tidak sedarkan diri.


Hospital Memorial King Chulalongkorn di Bangkok memaklumkan puteri raja itu sedang menerima rawatan berkaitan "jantung, paru-paru dan buah pinggang", menurut Royal Household Bureau.

Vietnam Post English

Puteri raja berusia 44 tahun itu dimasukkan ke hospital berkenaan sejak 15 Disember lalu akibat serangan jantung.


Menurut pasukan perubatan, keadaan puteri yang masih tidak sedarkan diri itu disebabkan aritmia dan jangkitan mycoplasma.


"Doktor masih terus memantau dengan teliti keadaan puteri," menurut kenyataan pihak istana.


Puteri Bajrakitiyabha, anakanda sulung Raja Thailand Raja Mahal Vajiralongkorn dilaporkan rebah ketika melatih anjingnya untuk kejohanan Working Dog Championship di wilayah Nakhon Ratchasima pada 15 Dis.


Puteri Bajrakitiyabha merupakan puteri tunggal Raja Vajiralongkorn dan isteri pertamanya, Puteri Soamsawali.






Sumber: BERNAMA

mojarean_X

@blastoff ada apa2 teori tak? Muda lg puteri tu

blastoff

mojarean_X replied at 9-1-2023 12:02 AM
@blastoff ada apa2 teori tak? Muda lg puteri tu

Kekayaan depa mencanak2 sejak syarikat raja thai itteww buat vaksin mRNA Astrazeneca for the 1st time, sebelum nih company tu tak untung sgt pungg  ....so depa satu kluarga provax ler yg buat duit dgn bunuh orgramai guna vaksin bioweapon itteww..... so anak pembuat vaksin pung kena aefi , what do you expect to happen when bioweapon masuk badan melainkan kiok je laaa, cuma lambat dgn cepat je membezakan kematian2 depa.



]]]]]]]]]]]]]]]]]]

https://www.reuters.com/business ... :~:text=Thai%20king,-Reuters&text=BANGKOK%2C%20Aug%2025%20(Reuters),began%20producing%20AstraZeneca%20Plc's%20(AZN.


Thai king's medical firm reports record profit after vaccine deal with AstraZeneca



Reuters











The signage of Siam Bioscience factory, where the vaccine against the coronavirus disease (COVID-19) will be produced, is pictured outside Bangkok, Thailand June 3, 2021. REUTERS/Soe Zeya Tun

BANGKOK, Aug 25 (Reuters) - Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began producing AstraZeneca Plc's (AZN.L) COVID-19 vaccine, government data shows.

The company is part of King Maha Vajiralongkorn's vast fortune, which includes land and property estimated at between $30 billion and $60 billion.

Founded in 2009 by the late King Bhumibol Adulyadej to produce biopharmaceuticals and improve public health, the company had since been loss-making and reported its first profit only in 2020 of 35.7 million baht ($995,000).

Its business improved sharply last year, as it began manufacturing vaccines for the first time.

Profit soared a whopping 4,650% to 1.69 billion baht and revenues increased by 1,500% to a record 4.9 billion baht, aided by its contract to manufacture 200 million doses of the Anglo-Swedish firm's COVID-19 vaccine.

The deal came under fire from a prominent Thai opposition politician who questioned why the contract went to a company that was owned by the king and had never made vaccines before.

mojarean_X

blastoff replied at 9-1-2023 08:17 AM
Kekayaan depa mencanak2 sejak syarikat raja thai itteww buat vaksin mRNA Astrazeneca for the 1st ti ...

Wow gilerr lah blastoff punya pendedahan